Product Categories
| Country: | China |
|---|---|
| Tel: | 021-65675885 |
| Mobile: | 18964387627 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| SPH3127 | C22H32N6O4 | 1399849-02-5 | Details |
| PF-03382792 | C23H32FN3O4 | 1400811-63-3 | Details |
| JAK-IN-3 | C18H20N4O3 | 1400876-94-9 | Details |
| Lifastuzumab vedotin | 1401812-88-1 | Details |
| Bermekimab | 1401965-15-8 | Details |
| Psiguadial D | C30H34O5 | 1402066-95-8 | Details |
| CKD-519 | C31H34F7NO3 | 1402796-27-3 | Details |
| EZH2-IN-13 | C34H45N5O3 | 1403255-41-3 | Details |
| Dimethylaminomicheliolide HCl | C17H28ClNO3 | 1403357-80-1 | Details |
| GSK572A | C22H21F4N5O | 1403602-32-3 | Details |
| Begelomab | 1403744-56-8 | Details |
| Muromonab | 140608-64-6 | Details |
| Bococizumab | 1407495-02-6 | Details |
| Ralpancizumab | 1407495-04-8 | Details |
| ZD-2138 | C23H24FNO4 | 140841-32-3 | Details |
| Silperisone HCl | C15H25ClFNSi | 140944-30-5 | Details |
| Tenatumomab | 1412891-40-7 | Details |
| Edobacomab | 141410-98-2 | Details |
| VUF-11222 | C25H31BrIN | 1414376-84-3 | Details |
| Sonelokimab | 1414386-05-2 | Details |
| IRE1α kinase-IN-2 | C27H23F3N6O | 1414938-21-8 | Details |
| ERG240 | C7H13NaO3 | 1415683-79-2 | Details |
| Sovleplenib | C24H30N6O3S | 1415792-84-5 | Details |
| Dapirolizumab pegol | 1416147-64-2 | Details |
| Vamotinib | C29H27F3N6O | 1416241-23-0 | Details |
| Dynole 2-24 | C24H41N3 | 1416313-72-8 | Details |
| PR-924 | C37H38N4O5 | 1416709-79-9 | Details |
| Amino-Tri-(carboxyethoxymethyl)-methane hydrochloride | C13H24ClNO9 | 1416771-72-6 | Details |
| Vevorisertib trihydrochloride | C35H39ClN8O | 1416775-08-0 | Details |
| Phenanthriplatin | C13H13ClN4O3Pt | 1416900-51-0 | Details |
| N 0861 | C13H17N5 | 141696-90-4 | Details |
| Xentuzumab | 1417158-65-6 | Details |
| Utomilumab | 1417318-27-4 | Details |
| PIM1-IN-1 | C25H30N8O2 | 1417630-95-5 | Details |
| TNIK-IN-7 | C23H22N4O2 | 1417795-24-4 | Details |
| TINK-IN-1 | C24H24N4O3 | 1417795-25-5 | Details |
| Sofituzumab vedotin | 1418200-58-4 | Details |
| SiR-COOH | C27H28N2O4Si | 1418275-26-9 | Details |
| Tisotumab | 1418628-81-5 | Details |
| Eldacimibe | C39H58N2O5 | 141993-70-6 | Details |
| 14-Epiandrographolide | C20H30O5 | 142037-79-4 | Details |
| Lapisteride | C29H40N2O3 | 142139-60-4 | Details |
| Lulizumab pegol | 1421830-13-8 | Details |
| BI-9627 hydrochloride | C16H20ClF3N4O2 | 1422252-46-7 | Details |
| Opicinumab | 1422268-07-2 | Details |
| Tafasitamab | 1422527-84-1 | Details |
| Antitumor agent-87 | C22H28N2O6S | 1422527-88-5 | Details |
| Acetazolamide sodium | C4H7N4NaO3S2 | 1424-27-7 | Details |
| Org 13011 | C18H25F3N4O | 142494-12-0 | Details |
| Org-13011 fumarate | C22H29F3N4O5 | 142494-13-1 | Details |
| Uplarafenib | C22H21F3N4O4S | 1425485-87-5 | Details |
| Luvadaxistat | C13H11F3N2O2 | 1425511-32-5 | Details |
| IND24 | C21H17N3S | 1426047-44-0 | Details |
| Lanadelumab | 1426055-14-2 | Details |
| APOBEC3G-IN-1 | C15H11NO3 | 14261-92-8 | Details |
| isomer-GAT 107 | 1426240-47-2 | Details |
| Tentoxin-d3 | C22H30N4O4 | 1426437-58-2 | Details |
| Labuxtinib | C20H16FN5O2 | 1426449-01-5 | Details |
| IHVR-17028 | C23H44N2O5 | 1428247-78-2 | Details |
| Pritelivir mesylate hydrate | C19H22N4O6S3 | 1428321-10-1 | Details |
| Usenamine A | C18H17NO6 | 1428417-60-0 | Details |
| HXJ42 | C15H15Cl2N5O | 1428640-39-4 | Details |
| Enlimomab | 142864-19-5 | Details |
| (S)-Baxdrostat | C22H25N3O2 | 1428652-16-7 | Details |
| STL1267 | C17H11ClN4O | 1429024-58-7 | Details |
| RapiFluor-MS | C21H25N5O5 | 1429047-69-7 | Details |
| Trevogrumab | 1429201-24-0 | Details |
| EN3356 | C16H13FN2OS | 1429329-63-4 | Details |
| H4R antagonist 1 | C11H11BrN8 | 1429375-54-1 | Details |
| Safingol hydrochloride | C18H39NO2. HCl | 139755-79-6 | Details |
| 3,3-Dimethylbutanoic acid-d9 | C6H12O2 | 1399294-95-1 | Details |
| ME-3221 | C22H21N5O2 | 139958-16-0 | Details |
| Romilkimab | 1399584-78-1 | Details |
| Triptoquinone A | C20H24O4 | 142950-86-5 | Details |
| Imalumab | 1430205-07-4 | Details |
| RS 56812 | C18H21N3O2 | 143137-37-5 | Details |
| PI3Kδ-IN-3 | C28H24N6O3 | 1431540-99-6 | Details |
| 1-[4-(1H-Imidazol-1-yl)phenyl]methanamine dihydrochloride | C10H12ClN3 | 1431966-12-9 | Details |
| TRPV3 antagonist 74a | C17H17F3N2O2 | 1432051-63-2 | Details |
| Sinitrodil | C10H10N2O5 | 143248-63-9 | Details |
| Carbaryl-d3 | C12H11NO2 | 1433961-56-8 | Details |
| MPO-IN-3 | C16H22ClN3O3S | 1435469-45-6 | Details |
| Quetiapine-d8 Hemifumarate | C25H29N3O6S | 1435938-24-1 | Details |
| RP 61499 | 143680-27-7 | Details |
| Larotinib | C24H26ClFN4O4 | 1438072-11-7 | Details |
| Glutaminase-IN-3 | C19H19F3N6O2S | 1439399-45-7 | Details |
| Lirequinil | C26H25ClN2O3 | 143943-73-1 | Details |
| ML 315 | C18H13Cl2N3O2 | 1440251-53-5 | Details |
| GRGDSPK acetate | 144027-77-0 | Details |
| TWIK-1/TREK-1-IN-3 | C19H27F3N2O2 | 1440532-33-1 | Details |
| BMS-963272 | C24H21F6N5O2 | 1441057-15-3 | Details |
| Lanopepden mesylate | C23H38FN7O7S | 1441390-17-5 | Details |
| WIN 51,708 | C29H33N3O | 144177-30-0 | Details |
| MM-401 TFA | C31H47F3N8O7 | 1442106-11-7 | Details |
| Calpain-2-IN-1 | C28H37N3O7 | 144231-85-6 | Details |
| Pasotuxizumab | 1442657-12-6 | Details |
| Firivumab | 1443004-15-6 | Details |
| Navivumab | 1443004-16-7 | Details |
| VU 0469650 | C22H28N4O | 1443748-47-7 | Details |
| Rofleponide | C25H34F2O6 | 144459-70-1 | Details |
| Product Total： Product Page： | ||||
| 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 | ||||